displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
Metoprolol tartrate USP, is a selective beta
1-adrenoreceptor blocking agent, available in 5-mL vials for intravenous administration. Each vial contains a sterile solution of metoprolol tartrate USP, 5 mg, and sodium chloride USP, 45 mg, and water for injection USP.
Metoprolol tartrate USP is (±)-1-(Isopropylamino)-3-[
p-(2-methoxyethyl)phenoxy]-2-propanol L- (+)-tartrate (2:1) salt, and its structural formula is:
Metoprolol tartrate USP is a white, practically odorless, crystalline powder with a molecular weight of 684.82. It is very soluble in water; freely soluble in methylene chloride, in chloroform, and in alcohol; slightly soluble in acetone; and insoluble in ether.
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3
Hypersensitivity to metoprolol and related derivatives, or to any of the excipients; hypersensitivity to other beta blockers (cross sensitivity between beta blockers can occur).
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
Metoprolol Tartrate Injection, USP is supplied as follows:
Metoprolol Tartrate Injection, USP (1 mg per mL)
||5 mg per 5 mL Single-Dose Vial
||10 vials per carton